eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. The company’s lead product candidate ...

U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or ...

Pfizer has teamed up with Effector Therapeutics to develop small molecule inhibitors of eukaryotic initiation factor 4E (eIF4E). Effector is set to receive $15 million upfront to work on drugs against ...

Pfizer is striking a deal with Effector Therapeutics, a San Diego–based startup that’s developing small-molecule drugs to inhibit hyperactive translation in tumors. The big pharma firm will pay ...